Intrathymic injection of SMX-1, a dualtropic murine leukemia virus (MuLV) originally derived from Moloney murine leukemia virus stocks, protects AKR mice from devel oping MuLV-accelerated leukemia and spontaneous leukemia. Thymuses of SMX-1-injected mice show no change in weight, morphology, or thymocyte size, and quantitative expression of Thy-i and Lyt-2 differentiation antigens is identical to control mice. The amplified thymic expression of MuLV-related antigens that occurs spontaneously in 6-month-old preleukemic AKR mice or that can be induced in young AKR mice by leukemogenic AKR dualtropic MuLV is prevented by SMX-1. It appears unlikely that the protective effect of SMX-1 is explicable in terms of cross-immunogenicity with transforming MuLV or transformed cells. As SMX-1 persists for long periods after intrathymic injection and does not alter levels of thymic ecotropic MuLV, SMX-1 may interfere with the generation, spread, or leukemogenicity of dualtropic MuLV that form de novo in AKR thymus during the late preleukemic phase. SMX-1 provides a way to probe the events leading to cell transformation in AKR mice.
ABSTRACT
Intrathymic injection of SMX-1, a dualtropic murine leukemia virus (MuLV) originally derived from Moloney murine leukemia virus stocks, protects AKR mice from devel oping MuLV-accelerated leukemia and spontaneous leukemia. Thymuses of SMX-1-injected mice show no change in weight, morphology, or thymocyte size, and quantitative expression of Thy-i and Lyt-2 differentiation antigens is identical to control mice. The amplified thymic expression of MuLV-related antigens that occurs spontaneously in 6-month-old preleukemic AKR mice or that can be induced in young AKR mice by leukemogenic AKR dualtropic MuLV is prevented by SMX-1. It appears unlikely that the protective effect of SMX-1 is explicable in terms of cross-immunogenicity with transforming MuLV or transformed cells. As SMX-1 persists for long periods after intrathymic injection and does not alter levels of thymic ecotropic MuLV, SMX-1 may interfere with the generation, spread, or leukemogenicity of dualtropic MuLV that form de novo in AKR thymus during the late preleukemic phase. SMX-1 provides a way to probe the events leading to cell transformation in AKR mice.
A number of factors are involved in the high susceptibility of AKR mice to leukemia development Early work by Furth, who developed the AKR strain, demonstrated the central role of the thymus (1) , and several years later, Gross proved that virus was involved in the etiology of the disease (2) . Subsequent isolation of leukemogenic viruses from other sources revealed that there was a family of leukemia viruses in the mouse (3) and that these viruses could be categorized into two major groups-G (Gross) and FMR (Friend, Moloney, Rauscher)-on the basis of virus-induced cell surface antigens (4) . Characterization of murine leukemia virus (MuLV) showed that different isolates from mice preferentially replicated in either mouse cells (ecotropic MuLV) or in cells of other species (xenotropic MuLV), and that ecotropic MuLV could be further subdivided by their predilection for growth in NIH Swiss (N-tropic) or BALB/c cells (B-tropic) (5 (5, 7) . Until recently, N-tropic MuLV was thought to represent the leukemogenic MuLV of AKR mice. However, a detailed study of the late preleukemic phase of AKR mice has led to another conclusion. Thymocytes of 6-month-old AKR mice were found to undergo a marked increase in expression of MuLV-related antigens (8) . No significant change in the level of ecotropic MuLV was detected during this period, but amplified antigen expression could be correlated with the emergence of MuLV with xenotropic properties (9) . Further studies showed that this MuLV was not a typical xenotropic MuLV, but had a number of unique characteristics, including the capacity to replicate in mouse cells as well as cells of other species (dualtropic) and the ability to produce characteristic foci in mink cells-namely, the MCF (mink cell focus-inducing) trait (10) . Neutralization and interference tests indicated that dualtropic MuLV shared features with both ecotropic and xenotropic MuLV, suggesting that these viruses arose de novo as a consequence of recombination between the envelope genes of ecotropic and xenotropic MuLV. This possibility has received considerable support from study of the gp7O (envelope) components (11) and oligonucleotide maps of dualtropic MCF viruses (12) . In contrast to the inability of ecotropic or xenotropic MuLV isolates from AKR mice to induce thymic MuLV-antigen amplification or accelerate leukemia development in AKR mice (13) , some dualtropic MCF isolates from AKR mice are highly active in both respects (13) (14) (15) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
(ecotropic MuLV), 69X9 (xenotropic MuLV), SC30 (AKR dualtropic MuLV), and 1504A (amphotropic MuLV)-have been described (13, 17, 18 Intrathymic Injection. Under light ether anesthesia, the sternal notch was exposed by a small incision in the midline of the upper thorax. A 27-gauge needle was inserted behind the notch into the right retrosternal area of the thorax and 0.15 ml was injected slowly into the thymus. The skin was closed by a single wound clip.
Thymic Biopsy. See ref. 21 . Leukemia Incidence. Mice were examined three times a week for leukemia development and sick mice were killed and autopsied. Mice with grossly enlarged thymus or thymus and lymphoid organs were classified as leukemic. If the thymus appeared normal in size, tissues were examined histologically to determine the cause of sickness or death. RESULTS Origin and Characterization of SMX-1 and 69L1 MuLV. SMX-1 is a cloned dualtropic (MCF) isolate of MuLV derived from a stock of Moloney murine leukemia virus that had been passaged exclusively in vivo. Initial recovery of MuLV from the murine leukemia virus stock was performed by Ulf Rapp (National Cancer Institute). The isolation procedure involved infection of C3H 10T1/2 cells with tumor extract followed by successive cocultivations of these infected cells with mouse SC-1 cells (1:9 ratio) and then feline embryo cells (FEC cells, 1:1 ratio). MuLV in FEC culture fluids (as determined by sedimentable RNA-directed DNA polymerase activity) was purified by three successive rounds of endpoint cloning on FEC cells. Rapp provided us with this virus in 1976 and it was further cloned in mink CCL64 cells at limiting dilution by a microtiter technique (19) in our laboratory. Virus clones were scored by replica plating in a focus-induction assay on S+L-mink cells (22) . Properties of one of these virus clones, designated SMX-1, are listed in Table 1. 69L1 is a cloned, dualtropic (MCF) isolate of MuLV with strong leukemogenicity derived from a virus-accelerated AKR leukemia as described (13) . Properties of 69L1 MuLV are also listed in Table 1 .
Accelerated Leukemia Development in 69L1-Injected AKR Mice: Effect of SMX-1. AKR mice were injected with SMX-1 by the intrathymic route. Two weeks later, these mice received 69L1 by the same route. Fig. 1 shows the rapid development of leukemia in mice injected with 69L1 alone. Mice receiving SMX-1 before 69L1 developed leukemia at a significantly slower rate, with a cumulative incidence approximating that seen in AKR control mice. Mice iniected with SMX-1 alone showed a considerably reduced incidence of leukemia, as compared to AKR control mice. tivity were tested for their effect on 69Ll-induced leukemia acceleration. These viruses were 69E5 (ecotropic MuLV), 69X9 (xenotropic MuLV), and SC30 (dualtropic MuLV). The leukemogenicity of 69L1 was not inhibited by prior intrathymic injection of these MuLV isolates.
Spontaneous Leukemia Development in AKR Mice: Effect of SMX-1. Fig. 2 (13) . SMX-1 does not amplify MuLV antigen expression by itself, but can prevent 69Ll-induced amplification (Fig. 3) . Similarly, SMX-1 injection of young AKR mice prevents the spontaneous amplification of MuLV-related antigens occurring in the thymus of 6-month-old AKR mice (Table 2) .
A number of other MuLV isolates lacking amplifying activity were tested for their capacity to prevent 69Ll-induced amplification. These viruses were 69E5, WN1802B, and Moloney (ecotropic MuLV); 69X9 (xenotropic MuLV); SC30 (dualtropic MuLV); and 1504A (amphotropic MuLV). None of these MuLV isolates inhibited 69Ll-induced thymic amplification of MuLV-related antigens.
Expression of Surface Alloantigens and MuLV-Related
Antigens by Thymocytes of SMX-1-Injected Mice. The effect of SMX-1 injection on the expression of Thy-i, Lyt-2, GIX, and H-2 antigens was measured by quantitative absorption tests (Fig. 4) . No Two weeks later, the SMX-1-or medium-injected mice were injected by the same route with either 69L1 or medium (see legend to Fig. 1 ). Thymocytes were obtained by thymic biopsy 24-29 days after the second injection and were tested for expression of MuLV-related surface antigens in cytotoxic tests.
thymocytes tested 43-144 days after SMX-1 injection. However, thymocytes from SMX-1-injected mice showed reduced expression of GIX antigen and an increased expression of H-2 antigen during this same time interval. This pattern of surface antigens in SMX-1-injected mice differed from that seen in amplified thymocytes from 6-month-old preleukemic mice (8) . Under these circumstances, GIX and H-2 levels are increased and Thy-i and Lyt-2 levels are decreased.
Body Weight and Thymic Structure in SMX-1-Injected Mice. Mice injected with SMX-1 appeared healthy and con- (18) or by passive administration of high titered MuLV antiserum (29, 30) or interferon (31, 32) 
